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1. Summary 
The overall goal of this research was to design, fabricate and evaluate a perfusion apparatus 
with a sample compartment yielding adequate sensitivity for nuclear magnetic resonance (NMR) 
studies of immobilized animal cells in horizontal 4.7 Tesla magnets. The system studied consisted 
of insulin-secreting recombinant mouse pituitary AtT-20 and mouse insulinoma I3TC3 cells 
entrapped as single cells or spheroid aggregates in calcium alginate/poly-L-lysine (PLL)/alginate 
microbeads. This system realistically simulates immunoisolated implantable devices, which have 
exceptional potential for the long-term treatment of endocrine disorders, primarily diabetes 
mellitus. Our work during the three years of the project focused on engineering functional, insulin-
secreting microbeads containing immunoisolated cells; on designing, fabricating and characterizing 
an NMR-compatible fixed bed reactor and support perfusion circuit which can maintain entrapped 
cells for prolonged periods and under various culture conditions; and on evaluating the 
bioenergetics and secretory function of entrapped AtT-20 spheroids on a long-term basis and of 
entrapped r3TC3 cells under zero and saturating glucose concentrations. Preliminary investigations 
on the effect of hypoxia on bioenergetics and insulin secretion from entrapped I3TC3 cells were 
also performed. 
2. Entrapped cell systems  
Our initial proposal included studies only with preparations of recombinant, insulin-
secreting AtT-20 cells. This is an excellent model system for fundamental studies on regulated 
and constitutive secretion and on the effect of entrapment on cell function. However, AtT-20 cells 
cannot be used in the development of a bioartificial pancreas because they are not glucose 
responsive and they also secrete pituitary hormones. We thus extended our studies to a system 
consisting of microbeads containing immunoisolated I3TC3 mouse insulinomas. The i3TC3 cell 
line (kindly provided by Dr. Shimon Efrat, Albert Einstein College of Medicine, Bronx, New 
York) regulates proinsulin biosynthesis and insulin secretion by the level of glucose in the medium 
and retains glucose responsiveness for about 50 generations in culture [4]. Implantation in diabetic 
rats of f3TC1 cells, an earlier variant of the 3TC3 line with similar properties, restored 
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normoglycemia for more than a month [5]. Thus, I3TC3 cells are promising for the development 
of an artificial pancreatic tissue that can be fabricated reproducibly at a medically relevant scale. 
3. Characterization of immunoisolated cell preparations  
An investigation was first carried out to characterize the stability of immunoisolated 
preparations of entrapped cells. Indeed, the cells used in our studies have a high growth potential, 
so it was necessary to examine if they grew in the alginate matrix, possibly rupturing the beads 
after prolonged cultivation. Even in the absence of bead rupture, growth of cells is undesirable 
since it results in the device secreting increased amounts of insulin. Increased insulin secretion 
may revert diabetes to hyperinsulinemia and hypoglycemia, a serious pathological condition. 
Experiments werefirst conducted with AtT-20 cells which exhibit little contact inhibition. 
If growth of these cells . could be suppressed without compromising function, the same could be 
true with more contact-inhibited cells, such as the f3TC3 line. Preliminary experiments showed 
that entrapped AtT-20 cells behaved best when they were preaggregated into spheroids and 
entrapped as such in the calcium alginate gel. Freshly trypsinized cells entrapped without 
preaggregation in calcium alginate and cells or spheroids encapsulated in hollow beads obtained by 
solubilization of the calcium alginate core showed inferior behavior [8]. 
AtT-20 spheroids were prepared by inoculating trypsinized monolayers in spinner flasks. 
By controlling the culture initiation and propagation parameters, spheroids increased in size with 
time but maintained a narrow size distribution [8]. Spheroids of 450 p.m average diameter were 
entrapped in calcium alginate/PLL/alginate beads of roughly 3 mm in diameter. The 
immobilization protocol used was similar to the procedure of Sun [12], except that the bead core 
was not solubilized after immobilization, so spheroids remained imbedded in the calcium alginate 
matrix. The cell loading was 3x10 7 cells/ml biopolymer [8,10]. This density of AtT-20 cells 
results in the system dynamics being controlled by the rate of reaction; diffusion through the 
immobilization polymer is not limiting [14,15]. The MW cutoff imposed by the calcium 
alginate/PLL/alginate system was found to be between 45 and 66 kDa [15]. Figures 1 in [8] and 1 
in [10] show a schematic and photomicrographs of the preparation. 
The metabolic and basal secretory functions of entrapped AtT-20 spheroids were evaluated 
and compared to those of free spheroid controls in long-term fed-batch and perfusion spinner flask 
cultures [8,10]. In free spheroid cultures, the total cell number and spheroid size increased with 
time; the overall metabolism and basal secretion increased to a lesser extent. This was probably 
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caused by an increase in nutrient-limited and/or necrotic cells as spheroid size increased. In 
entrapped spheroid cultures, the total cell number, the spheroid size and the overall metabolism and 
basal secretion remained roughly constant over a month. The specific metabolic and secretory 
rates were initially the same for free and entrapped spheroids, indicating no significant damage 
during immobilization. 
Immobilized 13TC3 cells behaved in a similar way over a period of two weeks when they 
were entrapped as single cells or small spheroids in calcium alginate/PLL/alginate. Thus, 
experiments with this system were carried out with the simpler preparation, i.e., cells from freshly 
trypsinized monolayers. Cells were entrapped at densities of 3-7x10' cells/ml. Cell viability after 
each step of the immobilization procedure was evaluated by the trypan blue exclusion method. 
Viability decreased from —97% in freshly trypsinized cells to —85% in calcium 
alginate/PLL/alginate beads.one day after addition of the PLL layer. This decrease is statistically 
significant but not detrimental to the usefulness of the preparation. A preliminary assessment of 
long-term viability was carried out by propagating entrapped 13TC3 cells in a spinner flask fed 
roughly every two days to maintain the glucose concentration above 1 mg/ml. Viability was 
—73% after 30 days in culture [9]. 
The responsiveness of entrapped PTC3 cells to changes in glucose levels was investigated 
next. Due to the hypersensitivity of OTC3 cells to glucose [4,13], the low glucose concentration 
used was 0 mM; the high glucose concentration was 25 mM. Secretion of insulin-related peptides 
(IRP) occurred at a rate above 60 1.1.U/10 5 cells-hr in the high glucose medium, and at roughly 6 
RU/105 cells-hr at zero glucose (Figure 3 in [9]). Thus, the preparation is glucose-responsive, at 
least for these two glucose levels. 
The above results indicate that entrapment in calcium alginate/PLL/alginate suppresses cell 
growth and stabilizes the metabolic and secretory activities of the preparation. The exact cause of 
growth suppression was not investigated, but it appears to be due to a combination of physical 
(space restriction) and chemical (reduced concentration of macromolecular nutrients) effects. In 
any case, this type of behavior is most promising for the development of stable artificial tissues 
based on transformed cells. 
4. Design of perfusion system  
Figures 5 A and B in [10] show a schematic of the bioreactor and the perfusion circuit used 
in NMR experiments with entrapped AtT-20 spheroids and PTC3 cells. The bioreactor was 
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cylindrical with a volume of 22 ml. It consisted of a glass tube with two Teflon end pieces. The 
bulk of medium in the perfusion loop was in a jacketed, aerated spinner flask (medium reservoir). 
Medium was circulated through the packed bed by a peristaltic pump at 30 ml/min. The pressure 
drop across the bed was approximately 30 cm of water. Spent medium was replenished with 
fresh at various flow rates. The liquid volume in the reservoir was maintained constant by 
positioning the medium withdrawal tube at a fixed level above the bottom of the flask. Dissolved 
oxygen and temperature were monitored at various places in the perfusion loop by sensors in flow-
through cells. The sensors were interfaced to a personal computer for continuous, on-line data 
acquisition, so that a "fingerprint" of the system operation was available at the end of each 
experiment. 
The perfusion system is equivalent to entrapped cells being suspended in a well-stirred 
vessel containing the same volume of medium as the perfusion loop. The advantage of the 
perfusion configuration is that cells are segregated from the bulk of medium, so relatively high cell 
densities are achieved within the radiofrequency (RF) coil where NMR signal is collected from. 
5. NMR spectroscopy and imaging 
NMR data were obtained with a horizontal bore SISCO 200/33 spectrometer operating at 
200.057 MHz for 'H and 80.984 MHz for 31P. The usable diameter of the bore was 12.5 cm, and 
the maximum gradient strength was 10 Gauss/cm. Data were acquired using a double-tuned 
31P/'H home built probe based on the modifications proposed by Chang et al. [1] on the original 
design of Schnall et al [11]. The radiofrequency antenna consisted of a loop-gap resonator that 
surrounded the cylindrical shape of the bioreactor. Typical acquisition parameters for the 31 P 
experiments were: 3000 Hz spectral width, 4096 complex points per free induction decay (HD), 
90° pulses, 3 seconds relaxation delay and 2048 transients. 1H NMR images were acquired with a 
spin echo sequence using an echo time of 50 ms, a repetition time of 2 s, a field of view of 6 cm, 
and a matrix of 128x128 phase-encoding steps [2,9,10]. 
6. RF homogeneity and packing uniformity  
RF homogeneity in the bed was investigated by obtaining 1 11 NMR images both transverse 
and parallel to the reactor axis. Perfusion was stopped during acquisition to avoid motion artifacts. 
Uniform bright images, outlining the shape of the bioreactor and free of field artifacts, were 
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observed, demonstrating the uniformity of the coil design (Figures 1A and B in [2]). 
To assess the packing uniformity of the bed, multiple slice NMR images of the reactor 
loaded with entrapped AtT-20 spheroids were obtained in directions both transverse and parallel to 
the reactor axis. Acquisition of these images under perfusion resulted in diminution of signal from 
the perfusate and demarcation of the alginate beads. Figure 6 in [10] shows a sequence of 'H 
NMR images transverse to the reactor axis. The packing uniformity can be clearly seen. When 
the NMR data were processed so as to obtain phase-sensitive images, the phase changes formed 
parallel bars in the absence of medium flow (Figure 7B in [10]). In the presence of flow, the 
phase bars were distorted at locales of higher medium velocity, such as interbead spaces (Figure 
7C in [10]). The phase-sensitive images show the absence of any gross flow channelling through 
the bed, indicating the prevalence of plug flow through the bioreactor. Such images were routinely 
obtained during the course of long-term experiments to ensure, along with visual observations, that 
the bed remained uniformly packed. 
7. Differential operation of the bed  
Under the operating conditions employed, dissolved oxygen (DO) is the only nutrient that 
can measurably decrease in a single-pass through the bed. By positioning DO probes in flow cells 
upstream and downstream from the reactor, it was found that the inlet DO concentration ranged 
from 40-75% air saturation, whereas the drop in DO across the bed was no more than 15% of the 
inlet value. Thus, both the inlet and outlet DO concentrations were well above the range where 
oxygen becomes limiting. 
A more thorough evaluation of the differential operation of the reactor was performed by 
acquiring 31P 1-Dimensional Chemical Shift Imaging (1D-CSI) spectra of entrapped AtT-20 
spheroids in directions transverse and parallel to the axis of the bed. Figure 3 in [2] shows 31 P 
NMR spectra acquired from slices orthogonal to the bioreactor axis. Similar spectra were also 
acquired from slices parallel to the bioreactor axis. Data from both experiments were analyzed by 
integrating the metabolite resonances in each spectrum, and calculating the following metabolite 
ratios: Per/Pi, P/13-NTP, and PCO3-NTP. The PME/PDE ratio was not calculated because the 
low signal-to-noise ratio of the spectra and the broad linewidth of the P i resonance did not allow for 
an accurate measure of these metabolites. No statistical differences were observed among the 
metabolite ratios in the various slices in both orientations (Table 1 in [2]). These experiments 
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demonstrate macroscopic homogeneity of cellular bioenergetics in the reactor and differential 
operation of the bed. 
8. Long-term study of immunoisolated AtT-20 spheroids  
Metabolic, secretory and bioenergetic indicators were followed on a long-term basis for 
immunoisolated AtT-20 spheroids. Concentrations of glucose and IRP were determined 
periodically in samples from the medium reservoir in the perfusion circuit. Figures 6A and B in 
[2] show the glucose and IRP concentration profiles, as well as the medium replenishment flow 
rate during the course of the experiment. Concentrations changed because of changes in the 
replenishment flow rate and/or because of changes in the metabolic and secretory activities of the 
culture. To differentiate between these two causes, concentration profiles were also simulated by 
solving the mass balance Equations for glucose and IRP and by assuming a Monod-type 
expression for glucose uptake and a constant specific IRP secretion rate. The simulation results are 
shown by the solid lines in Figures 6A and B in [2]. The model closely tracks the glucose and 
IRP data during the first 45 days of the experiment, but it deviates significantly from them 
thereafter. The increase in glucose and decrease in IRP concentrations measured experimentally 
during the later part of the experiment were apparently caused by cell death. 
31P NMR spectra of entrapped AtT-20 spheroids were collected continuously for a period 
of 70 days from the same cell preparation. Figure 4 in [2] shows a stack of representative spectra 
acquired during this experiment. Ratios of detectable metabolites were determined, and several 
temporal changes were observed. Specifically, the ratios P,/13-NTP and PCr/P-NTP changed 
slightly during the first 40 days, and then increased considerably (Figures 5A and 5C in [2]); the 
ratio of PCr/P i (Figure 5B in [2]) exhibited an almost linear decrease with time. The PME/PDE 
ratio exhibited what appeared to be a three-phased response with a sharp decrease between days 14 
and 20, followed by a slower decrease up to day 35, and then stabilizing until the end of the 
experiment (Figure 5D in [2]). Values of this ratio were not determined for the first 14 days, since 
PDE resonances were not detected during that period (Figure 4 [2]). The observed decrease of this 
ratio between days 10 and 30 was attributed to the continuing increase of the PDE metabolites. 
The ratio of the PME components, PC/PE, did not appear to exhibit a significant change during the 
experiment with the exception of the last three data points (Figure 5E in [2]). The higher values of 
these points are not significant due to the higher error in the calculation of the PE component of 
this ratio, and the overall lower signal-to-noise ratio of all metabolites during the last few days of 
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the experiment (Figure 4 in [2]). Finally the ratio of the PDE components, GPC/GPE, increased 
progressively from the day PDE resonances appeared (Figure 5F in [2]). 
9. Studies with immunoisolated OTC3 cells at various glucose concentrations  
Results reported in the literature indicate significant changes in islet cell bioenergetics, 
assessed by the ATP/ADP ratio, with glucose concentration in the surrounding medium [6,7]. To 
evaluate the bioenergetic changes of entrapped PTC3 cells induced by changes in glucose levels, 
31P NMR spectra were collected from cell-loaded microbeads perfused with medium containing 0 
or 16 mM glucose. Beads were first perfused with glucose-containing medium for approximately 
16-20 hours, then were switched to glucose-free medium for 4 hours, and the procedure was 
repeated three more times with a particular cell preparation. All media contained glutamine at 
approximately 6 mM. A total of five experiments of this type have been carried out with five 
different I3TC3 cell preparations. Figure 1 shows a set of typical results on P-NTP levels and IRP 
secretion at the two glucose concentrations. Results from all experiments agree that IRP secretion 
at 0 mM glucose occurred at a much lower rate than at 16 mM, but the 13-NTP level at 0 mM was 
not substantially different over the four-hour period from the P-NTP level at 16 mM. We are 
currently investigating possible differences in the levels of other cellular metabolites at the two 
glucose concentrations. 
10. Preliminary studies with immunoisolated PTC3 cells under hypoxia  
Results reported in the literature demonstrate a strong dependence of islet cell bioenergetics 
and insulin secretion on the level of DO in the surrounding medium [3,7]. Due to their 
transformed phenotype, pTC3 cells may be less susceptible to hypoxia, which would be a 
significant trait in tissue engineering applications involving these cells. Cells will experience 
hypoxic conditions after implantation due to the absence of vascularization and the diffusional 
limitations imposed by the alginate matrix. 
To carry out NMR and secretion studies at various DO levels, the perfusion system was 
modified by the introduction of a deoxygenator consisting of gas permeable silicone tubing in a 
glass shell. Medium flowed in the tubing and air or pure nitrogen was supplied in the shell. 
Figures 2 and 3 show typical sets of data obtained by switching from a high to a low DO level, as 
measured with a DO probe positioned approximately 12 feet from the bed. The [3-NTP level 
appeared to exhibit a decrease as DO was lowered, whereas the rate of IRP secretion did not 
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change. We are in the process of repeating this type of experiment at various DO levels to better 
evaluate the bioenergetic and secretory changes exhibited by entrapped cells. In any case, the type 
of secretory behavior indicated in Figures 2 and 3 is promising for the development of an artificial 
pancreatic tissue based on r3TC3 cells. 
11. Conclusions  
We have developed stable preparations of immunoisolated AtT-20 spheroids and 13TC3 
cells in calcium alginate/I'LL/alginate beads. We have designed, fabricated and characterized a 
fixed-bed perfusion bioreactor and support circuit which are compatible with a 4.7 T, horizontal-
bore NMR spectrometer and can maintain the entrapped cells in the long-term and under various 
culture conditions. This system allows the acquisition of 31 P NMR spectra at cell densities typical 
of tissue engineering applications. The RF field in the loop-gap resonator was uniform and cellular 
bioenergetics were the same at all places in the bioreactor. Levels of high-energy metabolites in 
immunoisolated AtT-20 spheroids remained roughly constant for 45 days under continuous 
perfusion, after which they rapidly declined as cell died. Preparations of entrapped j3TC3 cells 
secreted at a much lower rate at 0 versus 16 mM glucose, but NTP levels did not differ 
substantially at the two glucose concentrations when the zero glucose level was kept for up to 4 
hours. Reduced DO levels hand appeared to cause a decrease in NTP but no significant change in 
the rate of secretion. Aspects of OTC3 cell behavior indicate that an artificial pancreatic tissue 
based on these cells may be superior to one based on normal islets. 
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13. Figure captions 
Figure 1 	3-NTP levels and rates of IRP secretion from entrapped (3TC3 cells perfused with 
media containing 0 or 16 mM glucose. Calcium alginate/PLL/alginate beads of 1 mm diameter 
containing 7x10' cells/ml alginate were perfused with glucose-containing medium for 16-20 
hours, then switched to glucose-free medium for 4 hours, and the sequence was repeated three 
more times. TMP stands for tetramethylphosphate, a certain amount of which in a capillary tube 
in the fixed bed served to normalize the metabolite resonances. The Figure shows the 
P-NTP/TMP ratio and the IRP secretion rates during a zero glucose episode and during the four 
hours before and after the episode when beads were perfused with 16 mM glucose. 
Figure 2 	1.3-NTP levels and rates of IRP secretion from entrapped PTC3 cells perfused with 
media containing different DO levels. Calcium alginate/PLL/alginate beads of 1 mm diameter 
containing 7x107 cells/m1 alginate were perfused with aerated, glucose-containing medium for 16-
20 hours, then switched to glucose-containing medium with a reduced DO level for 5 hours. The 
reported DO levels were measured with a probe in a flow-through cell positioned approximately 
12 ft from the bioreactor. 
Figure 3 	Same as Figure 2, except that entrapped PTC3 cells were perfused with glucose- 
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